Cardiovascular implications of the COVID-19: Management of complications and drug safety concerns

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, has rapidly spread worldwide and has been infected more than 219 million individuals with 4.55 million deaths worldwide as of September 2021, causing a pandemic. Preexisting cardiovascular (CV) comorbidit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamidian, Maliheh, Ansari, Ramin, Zarshenas, Mohammad Mehdi, Foroughinia, Farzaneh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854922/
https://www.ncbi.nlm.nih.gov/pubmed/36685029
http://dx.doi.org/10.4103/jrms.jrms_895_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854922/
https://www.ncbi.nlm.nih.gov/pubmed/36685029
http://dx.doi.org/10.4103/jrms.jrms_895_21

Ejemplares similares